PTSGX
Price
$17.93
Change
+$0.12 (+0.67%)
Updated
Jul 31 closing price
Net Assets
1.99B
VIGAX
Price
$263.12
Change
+$2.98 (+1.15%)
Updated
Jul 31 closing price
Net Assets
379.21B
Interact to see
Advertisement

PTSGX vs VIGAX

PTSGX vs VIGAX Comparison Chart in %
View a ticker or compare two or three
VS
PTSGX vs. VIGAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTSGX is a Buy and VIGAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 379B vs. PTSGX (1.99B). VIGAX pays higher dividends than PTSGX: VIGAX (0.39) vs PTSGX (0.00). PTSGX was incepted earlier than VIGAX: PTSGX (26 years) vs VIGAX (26 years). PTSGX (1.20) is less costly to investors than VIGAX (0.05). PTSGX is a more actively managed with annual turnover of: 55.00 vs. VIGAX (12.00). PTSGX has a lower initial minimum investment than VIGAX: PTSGX (2500) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 12.36 vs. PTSGX (-4.37). VIGAX return over 5 years is better than : 72.79 vs. PTSGX (-11.41).
PTSGXVIGAXPTSGX / VIGAX
Total Expense Ratio1.160.052,320%
Annual Report Gross Expense Ratio1.200.052,400%
Fund Existence26 years26 years-
Gain YTD-1.0494.770-22%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.99B379B1%
Annual Yield % from dividends0.000.39-
Returns for 1 year-4.3712.36-35%
Returns for 3 years51.9575.4069%
Returns for 5 years-11.4172.79-16%
Returns for 10 years14.64359.074%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BST46.260.59
+1.29%
BlackRock Science and Technology Trust
JULB27.670.15
+0.54%
Aptus July Buffer ETF
DYLD22.26N/A
-0.02%
LeaderShares® Dynamic Yield ETF
FDEV37.15-0.31
-0.83%
Fidelity International Multifactor ETF
THNR25.40-0.47
-1.81%
Amplify Weight Loss Drug & Treatment ETF